AMCH Dibrugarh designated as Centre of Excellence for rare diseases

Also Read:MAMC launches cutting-edge Genetic Lab to tackle Rare Diseases

"Assam Medical College & Hospital, Dibrugarh, has been designated as a Centre of Excellence (CoE) for Rare Diseases under the National Policy for Rare Diseases (NPRD), 2021 by the Ministry of Health & Family Welfare, Government of India," it added, reports PTI.  

The notification mentioned that the responsibilities and activities of AMCH will be in accordance with the provisions mentioned under the National Policy for Rare Diseases (NPRD) 2021 and the instructions issued by the Centre from time to time.   

According to a TOI news report, with this designation, AMCH will operate under the provisions of NPRD 2021 and guidelines issued by the Ministry of Health and Family Welfare. The institution is expected to uphold the highest standards in rare disease management while contributing to national research efforts.    

Medical Dialogues had earlier reported that a major boost for healthcare in North India arrived today as Delhi CM Rekha Gupta and Health Minister Shri Pankaj Singh Ji inaugurated the cutting-edge Genetic Department and Lab for Rare Diseases at MAMC.

Slated to be one of the finest labs of its kind under MAMC, this facility is a testament to the remarkable efforts of Prof. Dr. Suresh Kumar, Professor of Medicine and a top physician of the country.   

Also Read:Delhi HC asks Centre to release Rs 10 Crore to AIIMS for treatment of rare diseases